Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Characterize the safety profile of the study drug in terms of adverse events, clinical laboratory tests, vital signs and electrocardiograms.
United States: Food and Drug Administration
|Fox Chase Cancer Center||Philadelphia, Pennsylvania 19111|
|Mayo Clinic Rochester||Rochester, Minnesota 55905|
|University of Colorado Cancer Center, Anschutz Cancer Center||Aurora, Colorado 80010|